Vitality Biopharma (OTC: VBIO) Cannabinoids to Treat Serious Neurological and Inflammatory Conditions

July 13, 2018 Editor Investor Presentations Comments Off on Vitality Biopharma (OTC: VBIO) Cannabinoids to Treat Serious Neurological and Inflammatory Conditions

Cannabinoids to Treat Serious Neurological and Inflammatory Conditions

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.




Related Articles

Newsmakers

FSD Pharma (OTC: FSDDF) Announces Signing of LOI with Solarvest to Develop and Test Pharma-Grade Cannabinoids out of Algae

February 6, 2019 Editor Newsmakers Comments Off on FSD Pharma (OTC: FSDDF) Announces Signing of LOI with Solarvest to Develop and Test Pharma-Grade Cannabinoids out of Algae

PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S) FSD Pharma Inc. (“FSD Pharma”)(OTC: FSDDF)  and Solarvest BioEnergy Inc. (SVS) (“Solarvest”) ()Parties”), a technology company which has developed an algal-based flexible production platform […]